Jazz Pharmaceuticals JAZZ Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's change in other assets?
- Jazz Pharmaceuticals (JAZZ) reported change in other assets of -$51.9M in Q1 2026.
- How has Jazz Pharmaceuticals's change in other assets changed year-over-year?
- Jazz Pharmaceuticals's change in other assets decreased by 7001.6% year-over-year, from $752K to -$51.9M.
- What is the long-term trend for Jazz Pharmaceuticals's change in other assets?
- Over 3 years (2021 to 2025), Jazz Pharmaceuticals's change in other assets has grown at a 228.8% compound annual growth rate (CAGR), from -$817K to -$29.03M.
- What does change in other assets mean?
- The change in miscellaneous short-term assets held by the company.
- How do you interpret change in other assets?
- An increase represents a cash outflow, while a decrease represents a cash inflow.
- How does change in other assets compare across companies?
- Common across all sectors; typically represents a small portion of total operating cash flow.